惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Vercel News
Vercel News
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
Apple Machine Learning Research
Apple Machine Learning Research
T
Tailwind CSS Blog
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
人人都是产品经理
人人都是产品经理
V
V2EX
量子位
Last Week in AI
Last Week in AI
Jina AI
Jina AI
博客园 - 【当耐特】
爱范儿
爱范儿
宝玉的分享
宝玉的分享
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
Hugging Face - Blog
Hugging Face - Blog
博客园 - 三生石上(FineUI控件)
有赞技术团队
有赞技术团队
小众软件
小众软件
IT之家
IT之家
博客园_首页
博客园 - 聂微东
S
SegmentFault 最新的问题
阮一峰的网络日志
阮一峰的网络日志
博客园 - 叶小钗

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Ardent Health, Inc. (ARDT) Presents at Bank of America Gl...
2026-05-14 · via All Articles on Seeking Alpha

Ardent Health, Inc. (ARDT) Bank of America Global Healthcare Conference 2026 May 13, 2026 11:00 AM EDT

Company Participants

Martin Bonick - President, CEO & Director
Alfred Lumsdaine - Chief Financial Officer

Presentation

Unknown Analyst

Thank you for joining us. It's my pleasure to be kicking off day 2 of the healthcare conference with Ardent Health. With us today, we have Marty Bonick, who's the CEO; and Alfred Lumsdaine who's the CFO. Dave Styblo from Investor Relations is in the audience as well. Maybe it makes sense to kind of start off. The company is a little bit different than some of the other hospital companies out there. Maybe just makes a little sense to start off with kind of how you guys think about growing your business, the growth strategy of Ardent.

Martin Bonick
President, CEO & Director

Yes. I'll start. Good morning, everybody. Great to see everybody here. Ardent Health is a health system that's grown to 30 hospitals, almost 300 sites of care across 8 states and 6 markets. Our markets are growing faster than the U.S. average, which has built in some tailwinds that we've benefited by since we've gone public, and I think people are getting to see. And we said from the onset that we've got a tri-part growth strategy. The first is improving margins inside of our core book of business and our IMPACT program, which I'm sure we'll get into today. reflects that activity. We said we were going to grow within our regions, those 8 markets, we're #1 or #2 in the majority of those markets, and we've got a unique joint venture partnership that we'll talk about some more as well that has allowed us to grow our inpatient share to leading positions, but we have room to grow our outpatient.